Beijing Strong Biotechnologies Receives Medical Device Registration for Thyroxine Uptake Assay Kit

Stock News
06/03

Beijing Strong Biotechnologies, Inc. (ASX: 300406) has announced that it has received a Medical Device Registration Certificate from the Beijing Medical Products Administration for its Thyroxine Uptake Assay Kit, which utilizes magnetic particle chemiluminescence immunoassay technology.

This kit is designed for the in vitro quantitative determination of thyroxine uptake (T-Uptake) in human serum or plasma.

The acquisition of this registration certificate enriches the company's product portfolio within the specialized field of in vitro diagnostic chemiluminescence.

This development is expected to enhance the company's core competitiveness and market expansion capabilities, positively impacting its future business operations.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10